Details
Category: Volume 08 Issue 08 August 2020
Hits: 967

Title: Association between Fasting Sugar Level, HbA1C Level and Serum Lipid Levels in T2DM Patients

Author: Abhishek Kumar Chandra

 DOI: https://dx.doi.org/10.18535/jmscr/v8i8.17

Abstract

Introduction: Diabetes Mellitus is one of the most common endocrinal diseases in the world. Incidences of this disease are increasing worldwide and this disease is called disease of this millennium. This study was undertaken to correlate fasting blood sugar level, Glycosylated haemoglobin (HbA1C) level and serum lipid levels in patients with diabetes mellitus.

Material and Methods: This study was a cross sectional study conducted on 100 patients of diabetes mellitus came to Kurji Holy Family Hospital, Patna, Bihar. The fasting blood sugar (FBS) levels, HbA1C levels and serum lipid levels were performed and then correlated fasting blood sugar level with HbA1C levels and FBS and HbA1C with serum lipid levels. There was a significant positive correlation between FBS and HbA1C, and FBS and HbA1C with serum cholesterol and serum triglycerides level and negative correlation with serum HDL- cholesterol levels.

Results: This study demonstrated that HbA1C level was increased in diabetics and it showed correlation with the status of control of diabetes.

Conclusion: Diabetics have got increased level of serum cholesterol, triglycerides and decreased levels of serum HDL-cholesterol. HbA1C showed stronger correlation with serum cholesterol and triglycerides as compared to FBS. HDL-cholesterol showed stronger correlation with FBS than HbA1C.

Keywords: Diabetes Mellitus (DM), Fasting Blood Sugar (FBS), Glycosylated Haemoglobin (HbAC), Serum Cholesterol, Serum Triglycerides, Serum HDL-Cholesterol.

References

  1. Harrison’s principles of internal medicine 20th edition: page no. 2850-2851
  2. Reimer F et al: Incidence of hyperlipoproteinemia in patients with chemical and clinical diabetes. Klin Wochenshr 1973; 51:973.
  3. Ricketts HT. Derangement vascular disease in diabetes Am J Med 1955;29:933.
  4. Sharma D, Bansal BC nad Prakash C. Serum lipid studies in insulin dependent diabetes below the age of 30 years. JIMA 1970;54:416.
  5. Sosenko JM, Breslow JL and Miettinen OS. Hyperglycemia and plasma lipid levels. A prospective study of insulin dependent diabetic patients. New Eng J Med 1980; 302:650.
  6. Pietri A, Dunn FL and Raskin P. The effect of improved diabetic control on plasma lipid and lipoprotein level: a comparison of conventional therapy and continuous subcutaneous insulin infusion. Diabetes 1980; 29:1001- 5.
  7. Somogyi M. and Nelson. Determination of blood sugar. J. Biochem. 19: 160, 1945.
  8. Paulsen P.:  Glycosylated  haemoglobin  in  childhood diabetes. Metabolism 1973;22: 269.
  9. Gabbay K.H. Glycosylated haemoglobin and diabetic control.(editorial) New.Engl.J.Med. 1976;295: 443.
  10. Elkeles R.S., Wu J. and Hambley J. Glycosylated haemoglobin, blood glucose and HDL-cholesterol in insulin requiring diabetics. Lancet 1978;2: 547.
  11. Kennedy L., Kandell T.W. and Merimee T.J. Serum protein bound hexose in diabetes. The effect of glycemic control. Diabetes 1979;28:1006.
  12. Nabarro J.D.N., Mustaffa B.E., Morris D. et al. Insulin deficient diabetes. Diabetologia 1979;16:5.
  13. Compagnucci P., Cartechni M.G., Bolli G. et al. The importance of determining irreversible glycosylated haemoglobin in diabetes. Diabetes 1981;30:607.
  14. Dinesh kumar and Gupta N.N: Serum cholesterol, phospholipids and betalipoproteins in untreated diabetics. J.A.P.I. 1967;15:357.
  15. Maleva I.J. A study of protein fractions and blood lipoproteins in diabetes. Abs. W. Med. 1961;30:229.
  16. Nikkila E.A. and Gormilla P. Serum lipids and lipoproteins in insulin treated diabetes. Demonstrations of increased HDL-cholesterol concentration. Diabetes 1978; 27: 1078-86.
  17. Akeel bai-Yaqobi, Adnan al-Khafaji, Dheaa K. Alomar. Thi-qui medic singh G and Kumar A al journal (T.Q.M.J.) 2011;52:39-44.
  18. Piia P., Simonen, Helena K. Gylling and Tatu A., Miettinen. Serum cholesterol level in diabetics. A.D.A. 2011. Page 17
  19. Lopes-Virella M.F., Wohltmann H.J., Loadholt C.B., and Buse M.G. plasma lipids and lipoproteins in young insulin dependent diabetic patients. Diabetologia 1981;21:216-23.
  20. Peterson C.M., Koenig R.J., Jones R.L., Saudek C.D. and Cerami A. Correlation of serum triglycerides levels and glycosylated haemoglobin concentration in diabetes mellitus. Diabetes 1977;26:507-509.
  21. Gonen B. and Rubenstein A.H., Rochman H., Tancga S.P. and Horwitz D.L. Glycosylated haemoglobin: an indicator of the metabolic control of diabetic patients. Lancet 1977;2:734-70.
  22. Gabbay K.H., Hasty K., Breslow J.L., Ellison R.C., Bunn H.F. and Gallop P.M. Glycosylated haemoglobin and long term blood glucose control in diabetes mellitus. J. Clin. endocr. meta 1977;44:859.
  23. Falko J.M., O Dorisio T.M. and Cataland S. Long term improvement of HDL-cholesterol and cholesterol/HDL- CH ratio in ambulatory type2 diabetics, treated using subcutaneous insulin pump. Diabetes. 1981;30:280.
  24. Samatha P, Venketeswarum and Siva Praboh. Journal of clinical and diagnostic research 2012;4302:0012.

Corresponding Author

Abhishek Kumar Chandra

Diabetologist, Kurji Holy Family Hospital, Patna, Bihar 800010, India